Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock

NCT04917497 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04917497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04917497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
April 30, 2014
Enrollment
43 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney failure, cardiogenic shock, cardiorenal syndrome